logo
15:46 Dec 05

Medicamen Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
381.10
-7.95 (-2.04%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Medicamen Biotech Ltd. Financials

Medicamen Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
381.10
-7.95 (-2.04%)
15:46 Dec 05
Quality
image/svg+xml

34/100
Low Financial Strength

Valuation
image/svg+xml

34/100
Mid Valuation

Technical

44/100
Technically Neutral

Strength

7

Weakness

9

Opportunity

1

Threats

0

3.34 %

ROE %

2.39 %

ROA %

7.49

EPS

167.35

BVPS

4.37 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
115.45 140.87 179.31 162.55 164.96
Operating Expenses +
91.9 116.99 157.07 148.68 150.11
Raw Material
55.69 81.8 109.54 90.65 86.61
Increase Decrease in Cost
-3.34 -9.71 -16.94 -6.03 -4.65
Other Manufacturing Expense
15.1 13.9 9.41 0 0
Employee Cost
14.5 20.44 30.07 31.87 33.32
Miscellaneous Expenses
9.95 10.56 34.67 32.19 34.83
Operating Profit
23.55 23.88 22.24 13.87 14.85
Other Income
1.72 2.46 2.33 6.24 6.21
Depreciation
5.77 6.37 7.09 7.07 6.35
Interest
1.4 2.92 4.4 3.16 3.55
Profit before tax and exceptio..
18.09 17.04 13.08 9.88 11.16
Exceptional Items
0 0 0 0 0
PBT
18.09 17.04 13.08 9.88 11.16
Provision for Taxation
3.2 2.32 3.58 3.32 2.69
Net Profit
14.9 14.73 9.49 6.56 8.49
NET Profit after MI
14.9 14.84 10.93 7.11 10.16
EPS
12.19 11.92 7.5 5.16 6.51
Operating Profit Margin (%)
20.4 16.95 12.4 8.53 9
Net Profit Margin (%)
12.91 10.53 6.1 4.37 6.16

Medicamen Biotech Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 40.50 40.50 43.20 43.00 43.00 43.00
FII 0.00 0.00 0.10 0.10 0.10 0.10
Public 0.70 0.70 0.80 0.90 1.10 1.10
Others 58.80 58.80 55.90 56.00 55.80 55.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: